Clinuvel Pharmaceuticals Ltd. (CUVL) Put/Call Volume History

Put/call volume ratio compares the number of put options traded to call options traded. Extreme readings can signal shifts in market sentiment relative to recent norms.

Clinuvel Pharmaceuticals Ltd. (CUVL) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $310.6M, listed on NASDAQ, carrying a beta of 0.57 to the broader market. Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Led by Philippe Jacques Wolgen, public since 2026-07-13.

Put/call volume history tracks trading activity and sentiment over time. No recent options activity for CUVL as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options volume is reported and how to read the data →